Pulmonary Exacerbations is a clinical construct denoting an acute worsening of respiratory symptoms and lung function in individuals with cystic fibrosis, distinguished from stable disease by the requirement for intensified therapeutic intervention.
4.3K
Publications
306.8K
Citations
19.6K
Authors
4.3K
Institutions
Publications per year
2017–2026
1.5K
Variants
Pulmonary Exacerbation
Parents
Publications
4.3K
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.6K citations · Full text
1–5 of 4.3K
Authors
19.6K
- JA
41
h-index
- FJ
36
h-index
- JV
34
h-index
- GJ
30
h-index
- SL
30
h-index
1–5 of 19.6K
Institutions
4.3K
Imperial College London
London, United Kingdom
77 h-index
491 publications
84.9K citations
University of Colorado Denver
Denver, United States
57 h-index
477 publications
33.2K citations
Brigham and Women's Hospital
Boston, United States
53 h-index
365 publications
31.3K citations
Harvard University
Cambridge, United States
52 h-index
307 publications
23.7K citations
University of Washington
Seattle, United States
49 h-index
249 publications
29.8K citations
National Jewish Health
Denver, United States
48 h-index
316 publications
23.3K citations
Royal Brompton Hospital
London, United Kingdom
47 h-index
183 publications
19.7K citations
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
Madrid, Spain
46 h-index
270 publications
18.6K citations
1–8 of 4.3K
Venues
- American Journal of Respiratory and Critical Care Medicine
AJRCCM · 185 publications · 39.8K citations
111
h-index
- European Respiratory Journal
210 publications · 26.1K citations
91
h-index
- Thorax
162 publications · 24K citations
87
h-index
- CHEST Journal
141 publications · 17.3K citations
77
h-index
- Pediatric Pulmonology
124 publications · 6.8K citations
48
h-index
1–5